Clinical Trial
doi: 10.1016/s0002-9394(01)01237-5.
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2
- PMID: 11755871
- DOI: 10.1016/s0002-9394(01)01237-5
Item in Clipboard
Clinical Trial
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2
Am J Ophthalmol.
2002 Jan.
No abstract available
Comment on
-
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.Am J Ophthalmol. 2001 May;131(5):541-60. doi: 10.1016/s0002-9394(01)00967-9. Am J Ophthalmol. 2001. PMID: 11336929 Clinical Trial.
Similar articles
-
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.Am J Ophthalmol. 2001 May;131(5):541-60. doi: 10.1016/s0002-9394(01)00967-9. Am J Ophthalmol. 2001. PMID: 11336929 Clinical Trial.
-
Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.Arch Ophthalmol. 2002 Nov;120(11):1443-54. doi: 10.1001/archopht.120.11.1443. Arch Ophthalmol. 2002. PMID: 12427056 Clinical Trial.
-
Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.Arch Ophthalmol. 1999 Oct;117(10):1329-45. Arch Ophthalmol. 1999. PMID: 10532441 Clinical Trial.
-
Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update.Retina. 2005 Feb-Mar;25(2):119-34. doi: 10.1097/00006982-200502000-00002. Retina. 2005. PMID: 15689800 Review.
-
Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes.Retina. 2002 Feb;22(1):6-18. doi: 10.1097/00006982-200202000-00003. Retina. 2002. PMID: 11884872 Review.
Cited by
-
Prognosis of untreated occult choroidal neovascularization.Graefes Arch Clin Exp Ophthalmol. 2007 Mar;245(3):376-84. doi: 10.1007/s00417-006-0424-1. Epub 2006 Oct 27. Graefes Arch Clin Exp Ophthalmol. 2007. PMID: 17072636
-
In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors.J Mammary Gland Biol Neoplasia. 2017 Sep;22(3):203-214. doi: 10.1007/s10911-017-9384-9. Epub 2017 Aug 18. J Mammary Gland Biol Neoplasia. 2017. PMID: 28822004
-
Photodynamic therapy with PhotoPoint photosensitiser MV6401, indium chloride methyl pyropheophorbide, achieves selective closure of rat corneal neovascularisation and rabbit choriocapillaris.Br J Ophthalmol. 2005 Jan;89(1):113-9. doi: 10.1136/bjo.2004.043075. Br J Ophthalmol. 2005. PMID: 15615758 Free PMC article.
-
Global research trends and future directions in diabetic macular edema research: A bibliometric and visualized analysis.Medicine (Baltimore). 2024 Jun 21;103(25):e38596. doi: 10.1097/MD.0000000000038596. Medicine (Baltimore). 2024. PMID: 38905408 Free PMC article.
-
A preliminary benefit-risk assessment of verteporfin in age-related macular degeneration.Drug Saf. 2006;29(3):189-99. doi: 10.2165/00002018-200629030-00003. Drug Saf. 2006. PMID: 16524319 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
